Results 31 to 40 of about 837,328 (317)
Importance The optimal approach to the use of venoarterial extracorporeal membrane oxygenation (ECMO) during cardiogenic shock is uncertain. Objective To determine whether early use of moderate hypothermia (33-34 °C) compared with strict normothermia ...
B. Levy+24 more
semanticscholar +1 more source
Background Venoarterial extracorporeal membrane oxygenation (va-ECMO) is an advanced life support for critically ill patients with refractory cardiogenic shock.
Saša Rajšić+6 more
semanticscholar +1 more source
Background: Cardiogenic shock is a serious complication of a ST-segment elevation myocardial infarction (STEMI). We compared short- and long-term mortality among (1) STEMI patients with and without cardiogenic shock and (2) STEMI patients with ...
Jesper Khedri Jensen+6 more
doaj +1 more source
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
BACKGROUND Cardiogenic shock is associated with substantial morbidity and mortality. Although inotropic support is a mainstay of medical therapy for cardiogenic shock, little evidence exists to guide the selection of inotropic agents in clinical practice.
Rebecca Mathew+21 more
semanticscholar +1 more source
Extracorporeal Membrane Oxygenation in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Cardiogenic shock is one of the main causes of death in patients with acute myocardial infarction with the mortality rates being as high as 60—80%. Extracorporeal membrane oxygenation (ECMO) is a life-saving technique in patients with cardiogenic shock ...
I. A. Kornilov+5 more
doaj +1 more source
Cardiogenic Shock in Pregnancy
(BJOG. 2024; 131:127–139. doi: 10.1111/1471-0528.17645) Overall, maternal morbidity in developed countries has decreased in recent years; however, data suggests this is mainly due to improved management of conditions, such as preeclampsia (PEC) and postpartum hemorrhage. However, other conditions related to pregnancy, such as cardiac disease,
Orene Y. O. Greer+4 more
openaire +4 more sources
Early risk stratification is essential to guide treatment in cardiogenic shock (CS). Existing CS risk scores were derived in selected cohorts, without accounting for the heterogeneity of CS.
B. Beer+9 more
semanticscholar +1 more source
Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high mortality, developing as a continuum, and progressing from the initial insult (underlying cause) to the subsequent occurrence of organ failure and death.
O. Chioncel+36 more
semanticscholar +1 more source
Background Lactic acidosis is associated with mortality in patients with cardiogenic shock (CS). Elevated lactate levels and systemic acidemia (low blood pH) have both been proposed as drivers of death.
J. Jentzer+8 more
semanticscholar +1 more source
The acute phase of experimental cardiogenic shock is counteracted by microcirculatory and mitochondrial adaptations. [PDF]
The mechanisms contributing to multiorgan dysfunction during cardiogenic shock are poorly understood. Our goal was to characterize the microcirculatory and mitochondrial responses following ≥ 10 hours of severe left ventricular failure and cardiogenic ...
Thor Allan Stenberg+7 more
doaj +1 more source